Form 144 RAPID MICRO BIOSYSTEMS For: 8 July
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rapid Micro Biosystems Inc (RPID)
The Rapid Micro Biosystems share price today is 1.7200, view NASDAQ RPID stock exchange data. Track the latest Rapid Micro Biosystems share price with real-time updates on RPID stock performance including market cap, day range, 52-week range and dividend yield. Access RPID charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7000
1.7700
52 wk Range
1.6600
4.9400
RPID is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.70001.7700
52 wk Range
1.66004.9400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RPID Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
6.6667
Upside
+287.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- Form 8K Rapid Micro Biosystems Inc For: 19 May
- Investing.com
- Form 144 RAPID MICRO BIOSYSTEMS For: 1 July
- Investing.com
- Form 424B5 Rapid Micro Biosystems Inc For: 19 May
- Investing.com
- Form 144 RAPID MICRO BIOSYSTEMS For: 22 June
- Investing.com
- Form 144 RAPID MICRO BIOSYSTEMS For: 8 July
- Investing.com
- Form 144 RAPID MICRO BIOSYSTEMS For: 1 July
- Investing.com
- Form 144 RAPID MICRO BIOSYSTEMS For: 22 June
- Investing.com
- Form 144 RAPID MICRO BIOSYSTEMS For: 10 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.6667
(+287.60% Upside)
Rapid Micro Biosystems Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue hit $8M (up 11% YoY), beating forecast by 4.85%; EPS of -$0.31 missed estimates by 24%, widening from -$0.26 in Q1 2025.
- Product revenue surged 36% to $5.6M on strong consumables demand; service revenue declined to $2.4M from $3.1M YoY, with gross margin flat at 5%.
- Operating expenses increased 17% due to non-recurring costs, pressuring path to profitability despite revenue growth momentum.
- Stock rose 1.94% after-hours to $2.63 despite missing EPS; company projects Q2 revenue of $7.8M and Q3 revenue of $10.55M.
- Management focuses on expanding installed base and improving margins; risks include rising costs and customer concentration with Samsung Biologics.
Last Updated: 14-05-2026, 02:56 am
Read Full TranscriptEarnings
Latest Release
13-05-2026
EPS / Forecast
-0.31 / -0.25
Revenue / Forecast
8M / 7.63M
Compare RPID to Peers and Sector
Metrics to compare | RPID | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRPIDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.7x | −1.8x | −0.4x | |
PEG Ratio | 0.20 | −0.22 | 0.00 | |
Price/Book | 4.2x | 5.5x | 2.6x | |
Price / LTM Sales | 2.5x | 4.2x | 3.0x | |
Upside (Analyst Target) | 302.3% | 6.3% | 49.7% | |
Fair Value Upside | Unlock | −3.6% | 7.3% | Unlock |
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Rapid Micro Biosystems (RPID) Share Price Today?
The Rapid Micro Biosystems share price today is 1.7200.
What is the current Rapid Micro Biosystems (RPID) share price and day range?
As of 08-07-2026, the Rapid Micro Biosystems share price is 1.7200, with a previous close of 1.7400. The share price has ranged from 1.7000 to 1.7700 today, while the 52-week range spans from 1.6600 to 4.9400.
What Is the Rapid Micro Biosystems Market Cap?
As of today, Rapid Micro Biosystems market cap is 84.0100M.
What Is the Rapid Micro Biosystems (RPID) Share Price Target?
The average 12-month share price target for Rapid Micro Biosystems is 6.6667, with a high estimate of 8 and a low estimate of 5. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +287.60% Upside potential.
What Is Rapid Micro Biosystems's Earnings Per Share (TTM)?
The Rapid Micro Biosystems EPS (TTM) is -1.1131.
When Is the Next Rapid Micro Biosystems Earnings Date?
Rapid Micro Biosystems will release its next earnings report on 31-07-2026.
From a Technical Analysis Perspective, Is RPID a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Rapid Micro Biosystems Trade On?
Rapid Micro Biosystems is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Rapid Micro Biosystems?
The stock symbol for Rapid Micro Biosystems is "RPID."
How Many Times Has Rapid Micro Biosystems Stock Split?
Rapid Micro Biosystems has split 0 times.
How Many Employees Does Rapid Micro Biosystems Have?
Rapid Micro Biosystems has 171 employees.
What Is the RPID After Hours Price?
RPID's last after hours stock price is 1.7100, the stock has changed by -0.0100, or -0.5800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.